Clovis Oncology, Inc. Files for Bankruptcy | Goodman & Nekvasil P.A. May Recover Investor Losses
Clovis Oncology, Inc. Files for Bankruptcy. Goodman and Nekvasil is investigating potential claims involving FINRA registered brokerage firms who may have unsuitably recommended investments in Clovis Oncology, Inc.
According to the SEC: Clovis Oncology Inc. filed FORM 25 for notification of removal from listing and/or registration of company stock under section 12(b) of the Securities Exchange Act of 1934.

Clovis Oncology, Inc. Bankruptcy
Investors in Clovis Oncology May Recover their Losses with Goodman & Nekvasil, P.A.
The recent bankruptcy filing for Clovis Oncology indicates that “unsecured noteholders” are owed more than $400,000,000. If you purchased an unsecured note from a registered representative of a broker dealer you may not have been suitable for the purchase.
Goodman & Nekvasil, P.A., a St. Petersburg, FL law firm with a national practice representing victimized investors, has recovered more than $300 million dollars on behalf of victimized investors.
All our cases are handled on a purely contingency fee basis by Kalju Nekvasil, Esq., formerly regional counsel with the NASD, now known as FINRA. Kalju Nekvasil, Esq. has practiced in this area of the law for more than 35 years.
There is no charge for an evaluation of your case. We handle our cases on a contingency fee basis. Unless we recover money for you, we charge no attorney’s fee. Unless you recover any money, you pay us nothing, not even the costs and expenses which the firm will advance on your behalf.
If you incurred investment losses in Clovis Oncology Inc. and would like your case evaluated by a securities attorney, please contact us.
Some of the information in this blog post was obtained on 1/10/23 directly from The SEC, without any changes. If you believe this information was reported incorrectly, please contact our firm at 1-800-500-4442.